Filter
2077
Text search:
operational
update
Featured
239
625
Language
Document type
951
373
325
155
141
54
39
27
7
2
2
1
Countries
102
71
62
61
51
51
49
46
43
40
40
37
36
35
34
33
30
28
27
25
23
22
21
21
21
20
19
19
18
18
18
18
16
15
13
13
12
12
12
11
11
11
10
10
9
8
8
8
7
7
6
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
856
165
140
114
70
27
27
Toolboxes
252
170
88
87
76
74
59
56
55
53
51
49
49
40
39
26
24
24
23
21
19
18
16
7
3
1
1
Accessed November 2017.
Policy framework.
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Lignes directrices.
Collection Avis et Rapports.
Manual for Early Implementation
Therapeutics Information and Pharmacovigilance Centre | TIPC
What We Know, What We Don’t Know, and What We Need to Do
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
